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A series of studies has shown that application of 
platelet-derived growth factor (PDGF) to a wound 
enhances the process of wound repair, especially in 
animals with wound-healing defects. In the current 
study, we investigated the regulation ofPDGF A and 
PDGF B and their receptors during wound repair in 
mice. Both ligands and both types of receptor were 
expressed in normal and wounded skin, whereby 
PDGF A and PDGF B proteins were found at different 
sites in the healing wound. Surprisingly, no signifi-
cant induction of these genes was observed after skin 
injury in normal mice, and expression levels were 
similar at all stages of the repair process. To deter-
mine a possible role of endogenous PDGF in normal 
wound healing, we subsequently analyzed the regu-
lation of PDGF and PDGF receptors during wound 
P latelet-derived growth . [:.actor (PDGF) has been . sug-gested to play a very important role in wound repair (Deuel et al, 1991; Pierce ef nl, 1991). PDGF is a disulfide-linked homo- or heterodimer of two subunits, an A-chai11 and a B-chain. All dimeric combinations 
(PDGF AA, PDGF BB, and PDGF AB) have been found in. ,Ji,,o, and 
different cell types produce characteristic mixtures of these three 
different forms of PDGF. The biologic activities of PDGF are 
mediated by two transmembrane tyrosine kinase receptors, termed 
A or a and B or {3 receptors. The A receptor can bind the A- as well 
as the B-chain, whereas the B receptor is specific for the B-chain of 
PDGF. Both the A and B receptors have been shown to induce 
mitogenic signals, but only the B receptor is able to mediate 
stinlUlation of chem.otaxis (reviewed by Heldin and Westermark, 
1996) . 
·PDGF is the principal mitogen in serum for mesenchymaUy 
derived cells ;md was the first growth fu.ctor shown to be chemo-
tactic for cells that migrate into healing wounds, such as neutro-
phils, monocytes, fibroblasts, and smooth muscle cells (reviewed by 
Heldin and Westennark, 1996). Prerequisites for a role for PDGF 
in wound healing are that PDGF be present at the wound site and 
that cells in the wounded area have PDGF receptors (PDGFRs) . 
Platelets are the major source ofPDGF in the body and release their 
contents after degranuJating at the site of injury. In JJitro, PDGF is 
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healing in healing- impaired animals. Genetically di-
abetic db/db mice showed a significant reduction in 
PDGF A and A-type receptor expression in non-
wounded and wounded back skin. Furthertnore, ex-
pression of the B-type receptor was also reduced 
during the repair process . Systemic glucocorticoid 
treatment caused a severe defect in wound repair that 
was accompanied by reduced expression of PDGF A 
and B and of the B-type receptor in the early phase of 
wound healing. These results provide an explanation 
for the beneficial effect of exogenous PDGF in the 
treatment of wound-healing disorders. Furthermore, 
our data suggest that a certain expression level of 
PDGF and its receptors is essential for normal repair. 
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also secreted by macrophages (Shimokado et al, 1985), fibroblasts 
(Paulsson et al, 1987), endothelial cells (Hadan et al, 1986), smooth 
muscle cells (Walker et a/, 1986), and keratinocytes (Ansel et a/, 
1993). PDGFRs are expressed by fibroblasts (Yarden et nl, 1986) , 
smooth muscle cells (Terracio et nl, 1988), microvascular endothe-
lial cells (Beitz et nl, 1991), and platelets (Vassbotn et nl, 1994). 
PDGF also has been shown to stimulate the production of matrix 
components by fibroblasts, such as fibronectin (Blatti et nl, 1988) 
and hyaluronic acid (Heldin et al, 1989), and it is also able to 
stimulate the contraction of collagen matrices (Clark et nl, 1989). 
Apart from these in JJitro results, the expression of PDGF and 
PDGFRs has also been demonstrated in JJiJJo during wow1d healing. 
Thus, PDGF-like peptides have been detected in WOlllld fluid 
(Matsuoka and Grotendorst, 1989; Soma et nl, 1992), and expres-
sion of PDGF ligands and receptors has been demonstrated in 
WOLmds of pigs and humans by in situ hybridization and immuno-
histochemistry (Antoniades et nl, 1991; Ansel ct nl, 1993; Reuter-
dahl et a/, 1993). The patterns of PDGF expression suggest a 
paracrine mechanism of action because the ligands seem to be 
expressed predominantly in the epidermis, whereas the receptors 
are found in the dermis . ln pig wounds, induction of the B receptor 
in the epidermis and increased expression of the B chain by dermal 
fibroblasts have been observed (Antoniades ef nl, 1991). 
Further support for an important role ofPDGF in wound healing 
comes from studies in which purified PDGF was added to wounds 
(reviewed by Deuel et nl, 1991; Pierce ct nl, 1991; Heldin and 
Westermark, 1996). Particularly in models of impaired wound 
healing, the addition ofPDGF had a beneftcial effect (Greenhalgh et 
nl, 1990). In a clinical trial, Robson et a/ (1992) demonstrated 
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improved healing of human decubitus ulcers by trea tment of the 
wounds with PDGF. 
The current study was unde rtake n to assess the regulation of 
endogenous PDGF during norm al and impaired w o und h ealing. 
Surprisingly, we found no induction of PDGF expression during 
wound healing in mice, but we demonstra te a substantial reduc tion 
in PDGF and PDGFR expression during wound repair in healing-
impaired animals, suggesting th at reduced expression of PDGF 
and / or PDGFRs mig ht be associated vvith the wound-healing 
defects in these mice. 
MATERIALS AND METHODS 
Glucoco.rticoid Trcattncnt of Mice Female BALB/c mice (3 mo old) 
were injec ted subcutaneously at 9 AM daily with 1 mg of dexamethasone 
(Sigma Chemical Company, St. Louis, MO) per kg body weight for 7 d . 
Dexamethasone was di ssolved in ethanol and dilu ted in saline. Control mice 
were treated with saline containing the same concentration of ethanol. 
Three glucocorticoid-treated mice and three control mice were injected 
with dexamethasone or saline to r another 5 d and left unwounded. T he 
o ther mice were wounded as described later. During the wound-healing 
period, dexamethasone was injected twice a day using a dose of 0.5 mg per 
kg body weight. · 
Wounding and Preparation of Wound Tissues Wounding and 
preparation of wound tissues were performed as described recently (Frank 
ct a/, 1996). Briefly , six full-thickness excisional wounds were generated on 
the backs of the mice by excising skin and panniculus ca rnosus. T he wounds 
were left uncovered without a dressing. Balb/c mice and C5 7BL/ KsJ-db/ m 
mice were used. The latter were chosen because the homozygous animals 
exhibi t characteri stics similar to tl10se of human adu lt-onset diabetes 
(Coleman, 1982) . At different times after injury, the complete wounds of 
four mice (N = 24 wounds), including 2 mm of the epithcl.ialmargins, were 
excised and immediately frozen in liquid nitrogen . To characterize the 
efl'ects of dexamethasone on PDGF and PDGFR. expression during wound 
healing, we analyzed the mice 1 and 5 d after injury. All experiments with 
anin1als w ere carri ed o ut with penuissio n fro 111 the local guvernn1ent of 
Bavaria or from the Animal Care Utilization Committee. 
lnttnunobistochctnistry The mice were sacri.fi ced at day 5 after 
wounding. Complete wounds were harvested, bisected , and frozen in tissue 
freezing medium. After ftxa tion in ace tone, the 6-!.l.m fi·ozen sections were 
treated with 1% H 20 2 in phosphate-bufrered saline to block endogenous 
peroxidase activ ity. Monospecific polyclonal antibodies for PDGF A and B 
(Santa Cruz Biotechnologies, Santa C ruz, CA) were diluted 1:250 in 
phosphate-buffered sa line and 0.1 'X. bovine serum albumin. Incubation of 
sec tions with antibod ies was performed overnight at 4°C. Slides were 
stained with the av idin-biotin-peroxidase complex system (Vector Labora-
tori es, Burlingame, C A) using 3-amino-9-ethylcarbazolc as a chromogenic 
substrate. After development, the slides were rinsed with water, counter-
stained with hem;ttoxylin , and mounted. 
Cell Culture Balbc/3T3 fibrobla sts, a murine ce ll line, and HaCaT 
keratinocytes, a human ce ll line (Boukamp et a/, 1988), were cultured in 
Dulbecco's modified Eagle's medium with l 0% fetal bovine serum (Gibco/ 
BRL, Paisley, UK) . To test the effects of glucocorticoids on PDGF and 
PDGFR expression, we grew the cell s to 50 - 70% confluence without 
changing the medium. They were subsequently treated w ith water-soluble 
dexamethasone (1 !LM, coupled to cyclodextrine) (Sigma) or with cyclo-
dex trine (Sigma) for different time periods and used for RNA isolation . 
RNA Isolation and RNase Protection Assay R.NA isolation was 
performed as described previously (C homczynski and Sacchi, 1987) . For 
RNase protection analysis , eDNA probes were cloned .into the transct;ption 
vector pBluesct;pt n KS( + ) (Stratagene, La J olla, CA) and linearized . An 
antisense transcript was synthesized i11 11itro by using T3 or T7 RNA 
polymerase and e2 P]rUT P (800 C i/ mmol; Amersham). Samples of20 or 40 
!Lg tota l RNA were hybridized overnight at 42°C with 1 00,000 cpm of the 
labeled antisense transcript. As a loading control, 1 !Lg of all RNA samp.les 
Were loaded on a 1% agarose gel before hybridization and wc~re stained with 
ethidium bromide. This staining also allowed us to determine the quality ·of 
the RNA. Hybrids were digested for 60 mi.n at 300C with R.Nases A and Tl, 
as described by Melton c/ a/ Cl 984). Protected fragments were separated on 
5% po lyacrylamide/8 M urea gels and analyzed by autoradiography. All 
protection assays were performed in duplicate or triplicate w ith difFerent sets 
of RNA from independent wound-hea ling or tissue culture experiments. 
T he regulation of mR.NA expression was quantified by laser scanning 
densitometry of the autoradiograms. 
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Figure 1. PDGF and PDGFR arc expressed in the dcrtnis and the 
epidermis of mouse tail. Mouse tail skin was separated from the 
underlying bone and i.ncnbated for 30 min at 37°C in 2 M NaBr. The 
epidermis was separated from the dermis, and both compartments of the 
skin were frozen in liquid nitrogen and used for RN A isolation . R.Nasc 
protection assays were performed with 20 !Lg or 40 !Lg (for PDGF B) of total 
RN A using radiolabelcd riboprobes complementary to PDGF and PDGFR 
ml"tNAs. H ybridiza tion probes (1000 cpm) were loaded in the lanes labeled 
"probe" and used as size markers. T he different intensities of tl1 ese baJJds 
reflect difl'erent exposure times. T he same b<Jtch of RNAs was used for all 
protection assays. The probes used tor hybridization are described in 
1\ifat.eria/s a111l Methods. One microgram of the same batch of l"tNAs is also 
shown (l~ji) . 
Probe DNAs Human and murine PGDF and PDGFR cDNAs were 
amplified by polymerase chain reaction using eDNA fi·om mouse wounds or 
HaCaT keratinocytes or human chromosomal DNA. T he fo llowing tem-
plates were used : 281-bp fr<Jgmcnt of human· PDGF A (nt 977-1258; 
Betsholtz et a/, 1986), 186-bp fi·agment of murine POGF A (nt 329 - 515; 
Mercola ct nl, 1990) . 23 1-bp fi·agmem of human PDGF B (nt 1078-1307; 
Collins et nl, 1985), 200-bp fragment of nnn·ine PDGF B (nt 3131-3331 ; 
Bonthron eta/, 1991) , 171-bp fragment of buman and murine PDGFR A (nt 
1604-1775; Claesson-Welsh ct a/ , ·1989), 231-bp fragment of human 
PDGFR B (nt 511-742; Gronwald et a/, 1988), and 177-bp fi·agmcnt of 
murine PDGFR B (nt 3114-3291; Yarden e/ a/, 1986) . 
R ESULTS 
Expression of PDGF and PDGFRs in the Dermis and Epi-
dermis Ta.i l skin of mice is the only site whe re the epidermis can 
be separated from the dermis, although h air follicles, which ar e 
surrounde d by an e pidermal layer, stick to the d ennis. To deter-
mine sites of expression of PDGF ligands and receptors in normal 
skin , we performed RNase protectio n assays usin g RNA isola ted 
from dermis and epidennis of the tail (Fig 1). Expression ofPDGF 
A w as detected in the dermis and at significantly lower levels in the 
epidermis . Messenger RNA e n coding PDGF B was found at very 
low levels in the dennis but was undetecta ble in the epidermis. 
Both receptors were hig hly expressed in the dermis, but no signal 
was detecte d with RNA fi.·om the epidermis. 
Expression ofPDGF and PDGFRs During Wound Healing 
To determine the time course of expression of PDGF ligands and 
receptors during the wound-healing process, we analyzed total 
RNA of normal back skin and of full-thiclmess excisional wounds 
at different stages b y RNase protection assays. For each time point, 
2 4 wounds from four mice were excised , combined, and u sed for 
RNA isolation . As shown in Fig 2, PDGF A and B as well as th eir 
receptors were expressed in normal mouse b ack skin. A comparison 
with Fig 1 revealed a significantly hig he r expression level of the 
ligands in back skin than in tai l skin. Surprisingly, n o signifi cant 
induc tion of PDGF and PDGFR expression was found after skin 
injury, and the expression levels of PDGF A even d ecline d \vi thin 
the first 24 h after woundin g (Figs 2, SA) . At day 5 after injm)', 
PDGF A expression had returned to the b asal le vel. In contrast to 
PDGF A, a minor induc tion of the A and B receptors was found 
dllling the fint 1-~ d after injury (Figs 2, SB,q. Expression of 
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Figure 2. Differential regulation ofPDGF and PDGFR expression 
during wound healing. Total RNA (20 J.Lg) of normal and wouJ1ded back 
skin was analyzed for the mRNA expression ofPDGF ligands and receptors 
by RNase protection assay. The time after wotmding is indicated at the top 
of each lane. T he same batch of RNA preparations was used for ali 
experiments in this fignre. H ybridization probes (1 000 cpm) were loaded in 
the Janes labeled "probe" and used as size markers. T he different intensities 
of these bands reAect different exposure times. The nega tive control 
cons isted of 50 J.Lg tRNA . One microgram of the same batch of R NAs is 
also shown (bollotu) . 
these genes returned to basal levels at day 5 or 7 after wounding. 
Expression of PDGF B was not affected by wounding, as similar 
mRNA levels were observed at all stages of the repair process. 
These results were reproduced with a different set ofRNAs from an 
independent wound-healing experiment. 
Localization of PDGF Proteins in the 5-d Mouse Wound 
To determine the sites of expression of PDGF in normal and 
wounded skin, frozen sections from 5-d fuU-thiclmess wol.mds 
w ere stained with antibodies against PDGF A and PDGF B. As 
shown in Fig 3A,B, PDGF A protein was found in the hyperpro-
liferative epithelium at the wound edge, particularly in suprabasal 
cells, but also in normal epithelium at a distance from the wound 
(data not shown). In addition, PDGF A was found in keratinocytes 
of the hair follicles and in a certain population of cells in the 
gra.nu.lation tissue that most likely represent fibroblasts and/ or 
m acrophages (Fig 3A,C). In contrast to PDGP A, no significant 
expression ofPDGF B was fow1d in the epithelium (Fig 3D,E), but 
PDGF B protein was present in the basement membrane zone and 
in the gnnulation tissue (Fig 3D,F). These results demonstrate a 
differential expression of PDGF A and B in the mouse wound. 
Expression of PDGF and PDGFRs Is Reduced in Normal 
Skin and During Wound Healing in the Diabetic Mouse 
Wound healing in the homozygous genetically diabetic mouse is 
markedly delayed but can be reversed by topical application of 
growth factors, including PDGF (Greenhalgh et al, 1990). This 
finding suggested that endogenous PDGF might be limited in the 
wounds of these mice. To address this question, we analyzed the 
expression of PDGF A and B and of the receptors in normal and 
wounded back skin of healthy control mice and diabetic mice by 
RNase protection assays (Figs 4, 5). Surprisingly, we fotmd 
significantly lower levels ofPDGF A and PDGFR A mRNA in the 
skin of diabetic mice than in control mice (Fig 4). A minor 
difference was observed for the B ligand, and B receptor levels were 
similar in normal and db/db mice. Figure 5 shows the mRNA 
regula tion of PDGF A and PDGF A- and B-type receptors during 
wound healing in normal and diabetic mice. Expression ofPDGF A 
mRNA declined after injury in db/ db mice, and minimal levels 
were observed at day 7 after wounding (Fig SA). By contrast, 
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expression of this ligand returned to basal levels at day 5 after irtiury 
in control mice (Figs 2, SA). These findings demonstrate a 
significantly reduced expression of PDGF A in normal and 
wounded skin of db/db mice compared with control mice, sug-
gesting that this growth factor might indeed be limited in diabetic 
mice. Tlus might also be the case for PDGF B, as PDGF B mRNA 
was hardly detectable in nonwounded and wounded skin of db/db 
mice (Fig 4 and data not shown). 
In addition to the ligands, expression of the receptors was lower 
during wound healing in db/db mice than in control nuce. Thus, 
PDGFR A mRNA was much lower in nonwounded skin of db/ db 
mice than in control mice (Fig 4). After inj ury, the degree of 
induction compared with nonwounded skin was similar in normal 
and diabetic mice (Fig SB), but tl1e absolute expression levels were 
much lower in db/db mice (Fig 4 and data not shown). Expression 
of PDGFR B (Fig SC) was slightly induced during normal wound 
healing. By contrast, PDGF B receptor mRNA levels were reduced 
in the genetically diabetic mouse until day 7. T hese results were 
reproduced with a different set of RNAs from an independent 
wound-healing experiment. T hese iu vi11o data demonstrate that the 
expression of PDGF and its receptors is severely affected in the 
diabetic mouse in normal skin as well as during wound healing. 
Glucocorticoids Have Differential Effects on PDGF Ligand 
and Receptor Expression in Normal Skin During Wound 
Healing and Iu Vitro To analyze a possible role ofPDGF and/ or 
PDGFRs in impaired wound healing of glucocorticoid-treated 
mice, we injected dexamethasone daily at 9 AM over a period of7 d 
before wounding and twice daily for 1- 5 d after wounding. Under 
these conditions, reepithelialization and granulation tissue forma-
tion were sigtuficantly reduced (data not shown and Brauchle et al, 
1995). Total RNA was isolated from nonnal back skin and from 
wounded skin of dexamethasone-treated mice and control nuce at 
day 1 or 5 after inj ury and was analyzed for PDGF and PDGFR 
expression . 
In nonwounded skin, expression levels ofPDGF A and PDGFR 
B were redu ced in glucocorticoid- treated mice compared wi.tb 
nonwounded skin of control mice (Fig 6) . T hese differences were 
also detected 1 d after wounding, whereas at day 5 after injm-y, 
PDGF A and PDGFR B were expressed at similar levels in normal 
and dexamethasone-treated mice. By contrast, expression of 
PDGFR A was not affected by injection of the steroid hormone . For 
PDGF B, there was a slight induction of expression in unwounded 
skin by dexamethasone but a repression at days 1 and 5 after 
wounding. Thus, treatment of mice with glucocorticoids modu-
lated the expression of the PDGF ligands and of the B receptor, so 
that expression of both ligands and also of th e B receptor was 
reduced during the early phase of wound h ealing in glucocorticoid-
treated mice. These results were reproduced with a different set of 
RNAs from an independent wound-healing experiment. 
To determine a possible direct effect of glucocorticoids on PDGF 
and PDGFR expression in skin-derived cells, we performed in vitro 
experiments . Cultured keratinocytes and fibroblasts were treated 
with 1 !J-M dexamethasone complexed with cyclodextrine and with 
cyclodextrine alone as a control during the exponential growth 
phase. In the human keratinocyte cell line, HaCaT, expression of 
PDGF A was slightly reduced within 2 and 6 h after addition of the 
glucocorticoid (Fig 7A) . In the murine Balbc/3T3 fibroblast cell 
line, the expression level of the A ligand was much lower than in 
HaCaT keratinocytes (compare Fig 1A,B) but the repression was 
stronger, particularly afte r prolonged treatment with dexametha-
sone. Expression of PDGF B was unaffected by dexamethasone in 
keratinocytes and could not be detected in fibroblasts (data not 
shown). Expression ofPDGFR type B was strongly downregulated 
in cultured fibroblasts by dexamethasone (Fig 8), whereas there 
was no expression in human keratinocytes (data not shown). These 
results were reproduced in three independent tissue culture exper-
iments. Taken together, these data demonstrate that expression of 
PDGF A by fibroblasts and keratinocytes and expression of PDGFR 
B by fib roblasts are also repressed by glucocorticoids in vitro. 
VOL. 109, NO. 2 AUGUST 1997 PDGF IN NORMAL AND IMPAIRED WOUND HEALING 135 
Figure 3. Localization ofPDGF proteins in 5-d full-thickness excisional mouse wounds by immunohistochemistry. Frozen sections from a 5-d 
lllouse wound were incubated with monospecific antibodies directed against PDGF A (A-C) and PDGF B (D-F) and were stained with the 
avidin-biotin-peroxidase complex system using 3-amino-9-ethylcarbazole as a chromogen ic substrate. Nuclei were cou.nterstained with hematoxylin. G, 
granulation tissue; H, hair follicle; HE, hyperproliferative epitheliw11. Scale bm>·: 1 fLITI (A ,D); 0.25 fL111 (B,C,E,F). 
DISCUSSION 
Because of its potent mitogenic and chemotactic activity for many 
cell types present in a wound, PDGF is thought to be one of the key 
players in the repair process . In tlus study, we examined the time 
course ofPDGF ligand and receptor expression during normal and 
impaired wound h ealing in mice. 
To our surprise, no sig11ificant upregulation of PDGF A and B 
expression was observed during wound healing, whereas expres-
sion of other growth factors was strongly induced under the same 
conditions (Werner et al, 1992; Frank et nl, 1995, 1996). In 
addition, no major differences in PDGHt expression were observed 
between normal and wounded skin. This is in contrast to studies of 
other groups, who found increased expression of PDGF B and 
PDGF B receptor in certain areas ofheal.ing human and pig wounds 
(Antoniadis et nl, 1991 ; Ansel et nl, 1993; Reuterdahl et a/, 1993). 
These results were obtained with either in situ hyb1idization or 
immunohistochemistry, which do not allow an absolute quantifi-
cation of rnRNA or protein levels in the complete wound. Thus, 
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Figure 4. Reduced expression of PDGF and PDGFRs in back skin 
of diabetic mice. Back skin ofllALB/c mice (control) and of homozygous 
genetica ll y diabetic (db/db) mice was isolated and used for RNA isolation. 
Tot:tl RNA (20 IJ.g) was ana lyzed by the l'l.Nase protection assay for 
expression of PDGF ligands :tnd receptors. Hybridization probes (1000 
cprn) were loaded in the lanes labeled "probe" and used as size markers. 
The different intensities of these bands reAect different exposure times. T he 
negative control consisted of 50 IJ.g tRNA. The same set of RNAs was used 
for all protection assays shown in tlus figure. 
upregulation in one area might be compensated by reduced expres-
sion in another area. We did not find significantly reduced expres-
sion of PDGF A or B in any area of wounded skin compared with 
control skin, however (Fig 3 and data not shown), suggesting that 
there is indeed no significant induction ofPDGF expression within 
the wound. Altematively , species-specific dill:erences might ex;st, 
an hypothesis supported by the different results obtained with 
human and pig wounds (Antoniadis et a/, 1991; Ansel et al, 1993; 
Reuterdahl et al, 1993). 
By immunohistochemistry, we demonstrated the presence of 
PDG.F A prote in in the epidermis of normal and wo~mded skin, 
whereas PDGF B protein was found only in the basement mem-
bran e zone below the epithelium. Whereas the strong expression of 
PDGF A in the epidem1is is consistent with previous findings (Ansel 
et a/, 1993), variable results have been obtained for PDGF B 
(Antoniadis eta/, 1991; Ansel et al, 1993; Reuterdah1 eta/, 1993). 
This might be due to the analysis at different times after iJJjury or to 
species-specific differences. In addition to the epidermis, PDGF A 
and B were found in a certaiJ1 population of ceUs in the granulation 
tissue, most likely fibroblasts or macrophages. 
The major source of PDGF u1 the wound , however, is the 
plate let, which releases its contents upon hemorrhage. In addition 
to other growth factors, platelets contain high levels of PDGF 
(reviewed by Heldin and Westermark, 1996), which is likely to 
initiate a cascade of other events including iJ1duction of expression 
of several growth and differentiation factors such as keratinocyte 
growth factor, vascular endothelial growth factor, and activm 
(Brauchle eta/, 1994; Fi.nkenzeller eta/, 1995; Hi.ibner and Werner, 
1996). In addition, PDGF is likely to attract many different cells into 
the wound such as neutrophils, macrophages, fibroblasts, and 
smooth muscle ceUs. Thus, PDGF might play its major role in the 
earliest phase of wound healing. 
A threshold level of PDGF might also be essential, however, at 
later stages of the repair process. To address this question, we 
analyzed the expression of PDGF and PDGFRs during the repair 
process iJ1 animals with wound-hea ling defects. The genetically 
diabetic db / db mouse has a defective leptin receptor and develops 
obesity, hyperglycemia, and insulin resistance (Coleman, 1982; Lee 
et a/, 1996) . Furthermore, it is characterized by a severe defect in 
wound hea ling because of a delay in cellu lar infiltration, granula-
tion tissue formation, and wound closure (Greenhalgh et a/, 1990). 
Most important, the wound-healing defect in these mice can be 
reversed by topical application of growth factors, including PDGF 
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Figure 5. Differential regulation of PDGF A, PDGFR A, and 
PDGFR B mRNA expression during wound repair in healthy and 
diabetic mice. Total RNA (20 IJ.g) from normal and wounded back skin 
of BALB/c mice (control) and of genetica lly diabetic db/ db mice was 
analyzed for expression of PDGF A (A), PDGFR A (B), and PDGHl B (C) 
by RNase protection assays. The intensities of the signals on the autoradio-
grams were quantified by laser scanning densitometry. Dotted li11es, re la tive 
levels of mRNA in wounded skin of control mice compared with non-
wounded skin of control mice; solid li11es, relative levels of mRNA ill 
wounded skin of db/db mice compared with nonwounded skin of db/db 
mice. The signals obtained with RNA from nonwounded skin of control 
mice and of db/db mice were arbitrarily defined as 1. Expression of PDGF 
B was not detectable in diabetic •nice at days 1 and 3 after wounding. The 
same batches of RNA were used for all experiments. 
(Greenhalgh et a/, 1990). Tl:lls findi11g suggests that endogenous 
PDGF might be illnited Ul these mice. In the present study, we 
demonstrated a dramatica lly reduced expression ofPDGF A and of 
the A receptor not only duru1g wound healing in db/db mice, but 
also iJ1 nonwounded skill of these animals. This finding suggests 
that cells that are present in normal skin such as fibroblasts, 
endothelial cells, or keratinocytes might have a reduced capacity to 
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Figure 6. Expression of PDGF and PDGFRs is differentially regu-
late d during wound healing in normal and glucocorticoid-treated 
mice. Balb /c mice were treated with glucocorticoids as described in 
Materia ls n11d Methods. Total RNA (20 f.Lg) of normal back skin and of 1- and 
5-d wounds of dexamethasone-treated mice (Dex) and of contro l mice 
(control , ctr.) was ana lyzed for expression ofPDGF ligands and receptors by 
RNase protection assays. H ybridization probes (1 000 cpm) were loaded in 
the lanes labeled "probe" and used as size markers. T he different intens ities 
of these bands reflect different exposure times. T he negative control 
consisted of 50 f.Lg tRNA. T he same batch of RNAs was used fo r all 
protection assays shown in tl~i s figure. One micwgram of the same batch of 
RNAs is also shown (botto111) . 
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Figure 7. Expression of PDGF A is downregulated b y glucocorti-
coids in cultured fibroblasts and keratinocytes. Exponentially grow-
ing H aCaT keratinocytes (A) and 3T3 fibrob lasts (B) were treated witli 
dexamethasone (Dex) or cyclodextrine (Cyc) for different times, as indi-
ca ted at the top of each lane. Nontreated cells (control) were used as an 
add itional negative control. Total cellular RNA (20 f.Lg) fi-om these cell s 
Was analyzed by RNase protection assay fo r the presence of PDGF A 
mRNA. Hybridization probes (1000 cpm) were loaded in the lanes labeled 
"probe" and used as size markers. The negative control consisted of 50 f.Lg 
t.R..NA. 
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Figure 8. Expression of PDGFR B is downregulated by glucocor-
ticoids in cultured fibroblasts. E"--ponentially growing Balbc/3T3 fibro-
blasts were treated with dexamethasone (Dex) (1 f.LM , dissolved in cyclo-
dextrine). Nontreated cells (control) or cyclodextrine-treated cells (Cyc) 
were used as controls. Cells were harvested at difl:crent times after tl1c 
addition of dexamethasone or cyclodextrine ru1d were used for RNA 
isolation. Total cellular RNA (20 f.Lg) was analyzed by RNase protection 
assay for the presence of PDGFR B mRNA. Hybridization probes (1 000 
cpm) were loaded in the lanes labeled "probe" and used as size markers . 
The negative control consisted of 50 f.Lg tRNA . The same batch of RNA 
was used for the protection assays in Fig 8 and Fig 7 B. 
express these genes. Furthermore, reduced expression ofB recep-
tors was observed during wow1d healing in these animals. Because 
PDGF is strongly chemotac tic and mitogenic for fi broblasts, re-
duced expression of PDGFRs by th ese cells might explain the 
delayed migration of fibrob lasts into the wound and the observed 
delay in granulation tissue formation. 
T he hypothesis for a role of PDGF and its receptors in impaired 
wound h ealing was fi.1rther supported by our d a ta obtained with 
g lucocorticoid-treated mice. Prolonged administration of these 
steroids leads to a rem arkable delay in wound repair and an increase 
in WOlmd complications (Wahl, 1989). T lus effect on wound 
h ealing may be due to the suppression of the inflammatory phase b y 
inhibition of infiltration of leukocytes and m acrophages (Ehrlich 
and Hw1t, 1968; Leibovich and Ross, 1975). In addition, direct 
efFects of glucocorticoids o n the genes involved in wound repair 
may be important. T hus, it h as been sh own that glucocor ti.coids can 
suppress th e express ion of keratinocyte growth factor (Brauchle et 
nl, 1995), oftra.nsfomtin g growth f<tcto rs {31 and {32 (Frank eta/, 1996), 
and of th e extracellular matri;x molecules collagen I and tenascin C 
(Weiner et al, 1987; Fassler et a/, 1996) . In tltis study, we fow1d 
significant reductions in PDGF A and PDGFR B mRNA not only in 
wounds, but also in nonwow1ded skin of glucocorticoid-treated ntice 
as well as iu llitro in cultured skin-derived cells, d emonso·ati.ng tl1at 
direct effects of gluco corticoids on these genes are also ilnportant. 
Our results suggest that reduced expression of PDGF and of its 
receptors might underlie, at least in p art, th e wound-healing defec t 
in diabe tic and glucocorticoid-treated n1.ice. PDGF has been sug-
ges te d to have two m<Uor but distinct roles in cutaneous wotmd 
repair: an earl y fi.m ction to stimulate fibrobla st proliferation and a 
later fw1c tion to indu ce the m yofi broblast phenotype (Clark, 1993). 
T h e .first function might be impaired by reduced responsiveness of 
the fibroblasts to PDGF and the second also b y reduced availability 
of th e ligands. 
Hie tha11k D r. P.H. Hofsc/J eiderjin support aud H. Riesemn1111 a11d F. To1terotot for 
excellellf teclwicnl assistn11cc. This 111ork 111ns s11pported l>y tl1c B1111desmillisterillmjiir 
Bild1111g 1111d Forsc/11111S n11d by n H emw1111 n11d Lilly Sc/Jilli11g A111nrd (to S . 117.). 
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